Century Therapeutics Inc (NQ: IPSC )
1.650
-0.010
(-0.60%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 13, 2024
Add to My Watchlist
All News about Century Therapeutics Inc
Benzinga's Top Ratings Upgrades, Downgrades For December 27, 2022
December 27, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/20/image15_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/22/screenshot_2022-11-22_at_7.24.03_pm.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/0c4efad5-3786-4f61-b572-f2b723ecedaa/small/century-primarylogo-pfade-rgb-rz-png.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_364.jpg)
Via Benzinga
Exposures
Product Safety
![](https://ml.globenewswire.com/media/0c4efad5-3786-4f61-b572-f2b723ecedaa/small/century-primarylogo-pfade-rgb-rz-png.png)
![](https://ml.globenewswire.com/media/0c4efad5-3786-4f61-b572-f2b723ecedaa/small/century-primarylogo-pfade-rgb-rz-png.png)
![](https://ml.globenewswire.com/media/0c4efad5-3786-4f61-b572-f2b723ecedaa/small/century-primarylogo-pfade-rgb-rz-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_28900.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
October 31, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/0c4efad5-3786-4f61-b572-f2b723ecedaa/small/century-primarylogo-pfade-rgb-rz-png.png)
Century Therapeutics to Present at the SITC 37th Annual Meeting
October 05, 2022
Via GlobeNewswire
![](https://ml.globenewswire.com/media/0c4efad5-3786-4f61-b572-f2b723ecedaa/small/century-primarylogo-pfade-rgb-rz-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/08/25/bz-pharma_2.jpg?width=1200&height=800&fit=crop)
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 25, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/25/bz-pharma_1.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/06/27/image9.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/05/09/yesterdays_movers.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2012/cell_therapy_national_human_genome.jpg?width=1200&height=800&fit=crop)
2 Natural-Killer Cell Therapy Oncology Companies Investors Should Watch
February 08, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_1886.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_96.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_368.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_426.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_3049.png)
![](https://mms.businesswire.com/media/20220110005266/en/1322562/4/Century_Logo.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_305.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_358.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_291.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-1872666_1920_98.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_272.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_271.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_363.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_357.jpg)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.